Annual Net Income
-$8.32 M
+$6.33 M+43.20%
01 June 2024
Summary:
Kintara Therapeutics annual net profit is currently -$8.32 million, with the most recent change of +$6.33 million (+43.20%) on 01 June 2024. During the last 3 years, it has risen by +$29.98 million (+78.28%).KTRA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$2.32 M
-$313.00 K-15.56%
01 June 2024
Summary:
Kintara Therapeutics quarterly net profit is currently -$2.32 million, with the most recent change of -$313.00 thousand (-15.56%) on 01 June 2024. Over the past year, it has increased by +$638.00 thousand (+21.54%).KTRA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$8.32 M
+$1.01 M+10.83%
01 June 2024
Summary:
Kintara Therapeutics TTM net profit is currently -$8.32 million, with the most recent change of +$1.01 million (+10.83%) on 01 June 2024. Over the past year, it has increased by +$4.70 million (+36.07%).KTRA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.2% | +21.5% | +36.1% |
| 3 y3 years | +78.3% | +61.0% | +66.4% |
| 5 y5 years | -3.4% | -44.7% | -8.6% |
KTRA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | -134.2% | >+9999.0% |
Kintara Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$8.32 M(-43.2%) | -$2.32 M(+15.6%) | -$8.32 M(-10.8%) |
| Mar 2024 | - | -$2.01 M(+96.6%) | -$9.33 M(-11.8%) |
| Dec 2023 | - | -$1.02 M(-65.5%) | -$10.58 M(-18.7%) |
| Sept 2023 | - | -$2.96 M(-11.2%) | -$13.02 M(-11.2%) |
| June 2023 | -$14.65 M(-35.4%) | -$3.33 M(+2.2%) | -$14.65 M(-12.6%) |
| Mar 2023 | - | -$3.26 M(-5.5%) | -$16.76 M(-11.1%) |
| Dec 2022 | - | -$3.45 M(-24.8%) | -$18.85 M(-11.5%) |
| Sept 2022 | - | -$4.60 M(-15.6%) | -$21.29 M(-6.0%) |
| June 2022 | -$22.66 M(-40.8%) | -$5.45 M(+1.7%) | -$22.66 M(-5.4%) |
| Mar 2022 | - | -$5.36 M(-9.1%) | -$23.95 M(-5.1%) |
| Dec 2021 | - | -$5.89 M(-1.2%) | -$25.23 M(+1.9%) |
| Sept 2021 | - | -$5.97 M(-11.4%) | -$24.75 M(-35.4%) |
| June 2021 | -$38.30 M(+319.7%) | -$6.73 M(+1.5%) | -$38.30 M(+8.2%) |
| Mar 2021 | - | -$6.63 M(+22.6%) | -$35.39 M(+15.2%) |
| Dec 2020 | - | -$5.41 M(-72.3%) | -$30.71 M(+13.6%) |
| Sept 2020 | - | -$19.52 M(+410.5%) | -$27.04 M(+196.3%) |
| June 2020 | -$9.13 M(+13.4%) | -$3.82 M(+95.4%) | -$9.13 M(+15.7%) |
| Mar 2020 | - | -$1.96 M(+12.5%) | -$7.89 M(+3.9%) |
| Dec 2019 | - | -$1.74 M(+8.3%) | -$7.59 M(-0.9%) |
| Sept 2019 | - | -$1.61 M(-37.8%) | -$7.66 M(-4.8%) |
| June 2019 | -$8.05 M(-27.7%) | -$2.58 M(+55.2%) | -$8.05 M(+2.6%) |
| Mar 2019 | - | -$1.66 M(-8.1%) | -$7.84 M(-13.9%) |
| Dec 2018 | - | -$1.81 M(-9.1%) | -$9.11 M(-12.9%) |
| Sept 2018 | - | -$1.99 M(-16.2%) | -$10.46 M(-6.1%) |
| June 2018 | -$11.14 M(+37.8%) | -$2.38 M(-18.9%) | -$11.14 M(-2.0%) |
| Mar 2018 | - | -$2.93 M(-7.2%) | -$11.36 M(+10.3%) |
| Dec 2017 | - | -$3.16 M(+18.6%) | -$10.30 M(+21.8%) |
| Sept 2017 | - | -$2.67 M(+2.5%) | -$8.46 M(+4.7%) |
| June 2017 | -$8.08 M | -$2.60 M(+39.2%) | -$8.08 M(-9.6%) |
| Mar 2017 | - | -$1.87 M(+41.3%) | -$8.94 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | - | -$1.32 M(-42.3%) | -$8.21 M(-13.9%) |
| Sept 2016 | - | -$2.29 M(-33.7%) | -$9.53 M(+7.5%) |
| June 2016 | -$8.86 M(+103.9%) | -$3.46 M(+203.1%) | -$8.86 M(+55.3%) |
| Mar 2016 | - | -$1.14 M(-56.9%) | -$5.71 M(-8.2%) |
| Dec 2015 | - | -$2.65 M(+63.2%) | -$6.22 M(+33.8%) |
| Sept 2015 | - | -$1.62 M(+441.4%) | -$4.65 M(+6.9%) |
| June 2015 | -$4.35 M(+55.3%) | -$299.50 K(-81.8%) | -$4.35 M(+7.4%) |
| Mar 2015 | - | -$1.65 M(+53.1%) | -$4.05 M(-27.7%) |
| Dec 2014 | - | -$1.08 M(-18.6%) | -$5.60 M(+3.9%) |
| Sept 2014 | - | -$1.32 M(-58.7%) | -$5.39 M(+31.9%) |
| June 2014 | -$2.80 M(-66.2%) | - | - |
| Mar 2014 | - | -$3.20 M(+269.4%) | -$4.08 M(-50.7%) |
| Dec 2013 | -$8.29 M(>+9900.0%) | -$866.00 K(-112.7%) | -$8.29 M(+11.6%) |
| Sept 2013 | - | $6.79 M(-199.7%) | -$7.43 M(-47.8%) |
| June 2013 | - | -$6.81 M(-8.0%) | -$14.23 M(+91.9%) |
| Mar 2013 | - | -$7.41 M(>+9900.0%) | -$7.41 M(>+9900.0%) |
| Dec 2012 | - | -$3200.00(-23.8%) | -$11.50 K(-40.1%) |
| Sept 2012 | - | -$4200.00(+320.0%) | -$19.20 K(+1.6%) |
| June 2012 | - | -$1000.00(-67.7%) | -$18.90 K(-23.5%) |
| June 2012 | -$18.90 K(-42.9%) | - | - |
| Mar 2012 | - | -$3100.00(-71.6%) | -$24.70 K(-2.8%) |
| Dec 2011 | - | -$10.90 K(+179.5%) | -$25.40 K(-12.7%) |
| Sept 2011 | - | -$3900.00(-42.6%) | -$29.10 K(-12.1%) |
| June 2011 | -$33.10 K(+491.1%) | -$6800.00(+78.9%) | -$33.10 K(+22.1%) |
| Mar 2011 | - | -$3800.00(-74.0%) | -$27.10 K(+15.8%) |
| Dec 2010 | - | -$14.60 K(+84.8%) | -$23.40 K(+125.0%) |
| Sept 2010 | - | -$7900.00(+887.5%) | -$10.40 K(+316.0%) |
| June 2010 | -$5600.00 | -$800.00(+700.0%) | -$2500.00(+47.1%) |
| Mar 2010 | - | -$100.00(-93.8%) | -$1700.00(+6.3%) |
| Dec 2009 | - | -$1600.00 | -$1600.00 |
FAQ
- What is Kintara Therapeutics annual net profit?
- What is the all time high annual net income for Kintara Therapeutics?
- What is Kintara Therapeutics annual net income year-on-year change?
- What is Kintara Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly net income year-on-year change?
- What is Kintara Therapeutics TTM net profit?
- What is the all time high TTM net income for Kintara Therapeutics?
- What is Kintara Therapeutics TTM net income year-on-year change?
What is Kintara Therapeutics annual net profit?
The current annual net income of KTRA is -$8.32 M
What is the all time high annual net income for Kintara Therapeutics?
Kintara Therapeutics all-time high annual net profit is -$5600.00
What is Kintara Therapeutics annual net income year-on-year change?
Over the past year, KTRA annual net profit has changed by +$6.33 M (+43.20%)
What is Kintara Therapeutics quarterly net profit?
The current quarterly net income of KTRA is -$2.32 M
What is the all time high quarterly net income for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly net profit is $6.79 M
What is Kintara Therapeutics quarterly net income year-on-year change?
Over the past year, KTRA quarterly net profit has changed by +$638.00 K (+21.54%)
What is Kintara Therapeutics TTM net profit?
The current TTM net income of KTRA is -$8.32 M
What is the all time high TTM net income for Kintara Therapeutics?
Kintara Therapeutics all-time high TTM net profit is -$1600.00
What is Kintara Therapeutics TTM net income year-on-year change?
Over the past year, KTRA TTM net profit has changed by +$4.70 M (+36.07%)